United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - simvastatin - oral suspension - 8mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - paracetamol, tramadol hydrochloride - film coated tablet - 37.5/325 milligram - other opioids

Israel - English - Ministry of Health

teva israel ltd - paracetamol - tablets - paracetamol 500 mg - paracetamol - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - paracetamol; tramadol hydrochloride - film-coated tablet - 37.5 mg/325 milligram(s) - opioids in combination with non-opioid analgesics; opiods in combination with non-opiod analgesics

United States - English - NLM (National Library of Medicine)

sebela pharmaceuticals inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 25 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Ireland - English - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - paracetamol; tramadol hydrochloride - film-coated tablet - 37.5/325 milligram(s) - other opioids; tramadol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

the boots company plc - paracetamol; pseudoephedrine hydrochloride; pholcodine - capsule, hard - 500/5/30 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - diclofenac potassium, quantity: 50 mg - oral liquid, powder for - excipient ingredients: potassium bicarbonate; saccharin sodium; mannitol; aspartame; glyceryl behenate; flavour - as short-term treatment (up to one week) for the relief of acute pain states in which there is an inflammatory component. treatment of acute migraine attacks (with or without aura). symptomatic treatment of primary dysmenorrhoea.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - baclofen - oral solution - 1mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sirolimus, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: polysorbate 80; propylene glycol; ethanol; ascorbyl palmitate; phosphatidyl choline; mono- and di- glycerides; soy fatty acids - indications as at 9 february 2004: rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.